Back to search

Article

Evaluation of A 55-Gene Classifier As A Prognostic Biomarker for Adjuvant Chemotherapy in Stage III Colon Cancer Patients

2021-06-17

Abstract excerpt

<h4>Background: </h4> Adjuvant chemotherapy reduces the recurrence risk in stage III colon cancer (CC). However, better prognostic and predictive biomarkers are required to stratify patients for treatment. We constructed a 55-gene classifier (55GC) and investigated its utility for classifying patients with stage III CC. Methods We retrospectively identified patients with stage III CC aged 20–79 years who received...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32e341ae-108b-5327-b0c0-64e6664b79b3
DOI
10.21203/rs.3.rs-579197/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of A 55-Gene Classifier As A Prognostic Biomarker for Adjuvant Chemotherapy in Stage III Colon Cancer PatientsDOI 10.21203/rs.3.rs-579197/v1
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity
Cell Glycolysis Related Gene Signature Predicts Survival of Patients with Colorectal CancerSemantic proximity
Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinomaSemantic proximity
Prognostic risk analysis related to radioresistance genes in colorectal cancerSemantic proximity
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.Semantic proximity
An SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection.Semantic proximity
Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancerSemantic proximity
Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy.Semantic proximity
Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtypeSemantic proximity
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.Semantic proximity
Prognostic Molecular Subtypes of Low-Grade Cancer of the AppendixSemantic proximity
Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.Semantic proximity
Select a neighboring publication to make it the new centre.